These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11401083)

  • 1. Thrombin converts singlet oxygen (1O2)-oxidized fibrinogen into a soluble t-PA cofactor. A new method for preparing a stimulator for functional t-PA assays.
    Stief TW; Kretschmer V; Kosche B; Doss MO; Renz H
    Ann Hematol; 2001 Apr; 80(4):189-94. PubMed ID: 11401083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antithrombotic factor singlet oxygen/light (1O2/h nu).
    Stief TW; Fareed J
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):22-30. PubMed ID: 10726045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood.
    Stief TW; Kurz J; Doss MO; Fareed J
    Thromb Res; 2000 Mar; 97(6):473-80. PubMed ID: 10704657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator.
    Stief TW; Marx R; Heimburger N
    Thromb Res; 1989 Oct; 56(2):221-8. PubMed ID: 2515607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
    Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin.
    Stief TW; Martín E; Jimenez J; Digón J; Rodriguez JM
    Thromb Res; 1991 Feb; 61(3):191-200. PubMed ID: 1827545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Singlet oxygen potentiates thrombolysis.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):259-78. PubMed ID: 17636188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):117-21. PubMed ID: 8457638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stimulatory effect of soluble fibrin on plasminogen activation by tissue plasminogen activator as studied by the Coa-set Fibrin Monomer test.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1991 Feb; 61(4):453-61. PubMed ID: 1905851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
    Eastman D; Wurm FM; van Reis R; Higgins DL
    Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
    Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M; Nakashima Y; Sueishi K
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
    Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers.
    Francis CW; Doughney K; Brenner B; Klingbiel K; Marder VJ
    Circulation; 1989 Mar; 79(3):666-73. PubMed ID: 2465100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
    Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
    Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single chain-urokinase binds to oxidized fibrin(ogen) derivatives.
    Stief TW; Martin E; Digon J; Martin-Noya A; Parody R; Rodriguez JM
    Thromb Res; 1990 Jul; 59(2):351-61. PubMed ID: 2122541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.